Catalent
CTLT
#1574
Rank
$10.75 B
Marketcap
$59.25
Share price
0.58%
Change (1 day)
66.76%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

Catalent (CTLT) - Total debt

Total debt on the balance sheet as of September 2024 : $4.94 Billion USD

According to Catalent's latest financial reports the company's total debt is $4.94 Billion USD. A companyโ€™s total debt is the sum of all current and non-current debts.

Catalent - Total debt on balance sheet (from 2013 to 2024)

Total debt by year

Year Total debt Change
2023-06-30$4.86 B15.28%
2022-06-30$4.21 B29.44%
2021-06-30$3.25 B7.39%
2020-06-30$3.03 B2.49%
2019-06-30$2.95 B8.75%
2018-06-30$2.72 B30.85%
2017-06-30$2.07 B11.78%
2016-06-30$1.86 B-1.08%
2015-06-30$1.88 B-30.61%
2014-06-30$2.71 B0.71%
2013-06-30$2.69 B0.3%
2012-06-30$2.68 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
$38.15 M-99.23%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.33 B-93.19%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.20 B 25.37%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
$0.22 B-95.47%๐Ÿ‡บ๐Ÿ‡ธ USA